AstraZeneca reaffirms outlook after a leak to sell-side analysts

AstraZeneca reaffirmed short and medium-term forecasts this morning after an inadvertant leak of an out-of-date spreadsheet templeta to sell-side analyst community in connection with a routine consensus estimate collection process had raised some questions. AstraZeneca maintains 2011 expextations communicated on December 20th.